BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

Women with TN breast cancer diagnosed below 50 years have >10% likelihood of carrying a BRCA1 mutation and are therefore eligible for testing in most centres. However, implementation may place short-term logistical and financial burdens on genetic services.